| StockChase

View Opinion

Stock SymbolAbbVie Inc. (ABBV-N)
Source of InformationMarket Call Tonight (BNN TV)
T.V. Program Date2017-04-20
Opinion

(A Top Pick Dec 23/16. Up 4%.) A one trick pony with their drug Humira. Valuation is quite reasonable and is going to be 12-13X projected earnings. A lot of that is based on sales of Humira, a life altering drug, which accounts for over 60% of their revenues. Made 2 very large acquisitions in the past few years, and we are starting to see some of those drugs in the pipeline getting approved.

Price (as of program date)$63.780
Implied Signal
$ Goal
ExpertLorne Zeiler
T.V. Program TopicDIVIDEND STOCKS AND MACRO STRATEGIES
Expert's BiasUNKNOWN
Own or RelationshipYes